HIV Disclosure and Medication Adherence, a Pilot Study (RSAD-VIH-11)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01621412 |
Recruitment Status
:
Completed
First Posted
: June 18, 2012
Last Update Posted
: December 22, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
HIV Infection |
Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.
Adherence is measured by electronic monitoring and pill count.
Study Type : | Observational |
Estimated Enrollment : | 120 participants |
Observational Model: | Cohort |
Time Perspective: | Cross-Sectional |
Official Title: | HIV Disclosure and Medication Adherence, a Pilot Study |
Study Start Date : | April 2012 |
Actual Primary Completion Date : | June 2013 |
Actual Study Completion Date : | June 2013 |

- Patient Adherence [ Time Frame: 30 days before survey ]Electronic monitoring of adherence during 30 days before survey
- Patient Adherence [ Time Frame: 90 days before survey ]Electronic monitoring of adherence during 90 days before survey

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- HIV Infection
- Enrolled in the adherence-enhancing program
Exclusion Criteria:
- Inclusion visit
- Not french or english speaker

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01621412
Switzerland | |
Policlinique Médicale Universitaire | |
Lausanne, Vaud, Switzerland, 1011 |
Principal Investigator: | Marie-Paule Schneider, PhD | Policlinique Médicale Universitaire | |
Principal Investigator: | Aurélie Gertsch, PhD-Student | Policlinique Médicale Universitaire | |
Study Chair: | Olivier Bugnon, Professor | Policlinique Médicale Universitaire | |
Study Chair: | Matthias Cavassini, MD | Centre Hospitalier Universitaire Vaudois |
Responsible Party: | Marie Schneider, Pharmacist, PhD, Policlinique Médicale Universitaire |
ClinicalTrials.gov Identifier: | NCT01621412 History of Changes |
Other Study ID Numbers: |
RSAD-VIH-2011 |
First Posted: | June 18, 2012 Key Record Dates |
Last Update Posted: | December 22, 2015 |
Last Verified: | December 2015 |
Keywords provided by Marie Schneider, Policlinique Médicale Universitaire:
Medication Adherence HIV infection Disclosure |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |